Medical Dosimetry
Volume 35, Issue 3 , Pages 179-194 , Autumn 2010

Ion Stopping Powers and CT Numbers

  • Michael F. Moyers, Ph.D.

      Affiliations

    • Department of Proton Therapy, Inc., Colton, CA
    • Corresponding Author InformationAddress correspondence to: Michael F. Moyers, Ph.D., Proton Therapy, Inc., Colton, CA 92324
  • ,
  • Milind Sardesai, Ph.D.

      Affiliations

    • Department of Long Beach Memorial Medical Center, Long Beach, CA
  • ,
  • Sean Sun, M.S.

      Affiliations

    • Department of City of Hope National Medical Center, Duarte, CA
  • ,
  • Daniel W. Miller, Ph.D.

      Affiliations

    • Department of Loma Linda University Medical Center, Loma Linda, CA

Received 22 January 2009 ,Accepted 13 May 2009.

References 

  1. Fowler JF. Nuclear Particles in Cancer Treatment. In: Bristol: Adam Hilger Ltd; 1981;p. 6
  2. Moyers MF. “Proton therapy” in Modern Technology of Radiation Oncology: A Compendium for Medical Physicists and Radiation Oncologists. In: Wisconsin: Medical Physics Publishing; 1999;p. 823–869
  3. Janni JF. Proton range-energy tables, 1 keV - 10 GeV. Atomic. Data. Nuclear. Data. Tables. 1982;27:147
  4. Geise RA, McCullough EC. The use of CT scanners in megavoltage photon-beam therapy planning. Radiology. 1977;124:133–141
  5. Urie MM, Goitein M, Doppke K, et al. The role of uncertainty analysis in treatment planning. Int. J. Radiat. Oncol. Biol. Phys. 1991;21:91–107
  6. Coolens C, Childs PJ. Calibration of CT Hounsfield units for radiotherapy treatment planning of patients with metallic hip prostheses: the use of the extended CT-scale. Phys. Med. Biol. 2003;48:1591–1603
  7. Schneider U, Pedroni E, Lomax A. The calibration of CT Hounsfield units for radiotherapy treatment planning. Phys. Med. Biol. 1996;41:111–124
  8. Wrightstone T, Crowell C, Urie M, et al. The Treatment Planning Program (RX): The User's Manual. Boston, MA: Massachusetts General Hospital; 1989;8–1
  9. Miller, D.W.; Moyers, M.F. Treatment planning system design considerations for tissue motion and uncertainties. Proton Therapy Co-operative Group XXX, April 12–15, 1999, Cape Town, South Africa.
  10. Battista JJ, Rider WD, van Dyk J. Computed tomography for radiotherapy planning. Int. J. Radiat. Oncol. Biol. Phys. 1980;6:99–107
  11. Battista JJ, Santon LW, Bronskill MJ. Compton scatter imaging of transverse sections: Corrections for multiple scatter and attenuations. Phys. Med. Biol. 1977;22:229–244
  12. Simpson RG, Ghen CT, Grubbs EA, et al. A 4 MV CT scanner for radiation therapy: The prototype system. Med. Phys. 1982;9:574–579
  13. Jeraj R, Mackie RR, Balog J, et al. Radiation characteristics of helical tomotherapy. Med. Phys. 2004;31:396–403
  14. Mustafa AA, Jackson DF. The relation between x-ray CT numbers and charged particle stopping powers and its significance for radiotherapy treatment planning. Phys. Med. Biol. 1983;28:169–176
  15. Schaffner B, Pedroni E. The precision of proton range calculations in proton radiotherapy treatment planning: Experimental verification of the relation between CT-HU and proton stopping power. Phys. Med. Biol. 1998;43:1579–1592
  16. Moyers MF, Miller DW, Siebers JV, et al. Commissioning of site specific treatment planning tools. Particles 10. Vancouver, Canada: Presented at the Proton Therapy Co-operative Group XVI; 1992;March 30–31, 1992
  17. Moyers MF, Miller DW, Siebers JV, et al. Water equivalence of various materials for 155 to 250 MeV protons. Med. Phys. 1992;19:829
  18. Moyers, M.F. Minimally perturbing head and neck registration and immobilization devices. Presented at the Particle Therapy Co-operative Group meeting, Bloomington, Indiana, October 10–13, 2004.
  19. Moyers, M.F.; James, M.R.; Waters, L.S.; et al. Upgrade and verification of MCNPX for HZE ions. Presented at the 16th Annual NASA Space Radiation Investigators' Workshop, Port Jefferson, New York, May 15–18, 2005.
  20. Moyers MF, Sun S, Sardesai M, et al. Tomotherapy MVXCT numbers versus RLSP for various ions and materials. Med. Phys. 2007;34:2293;Presented at the Annual Meeting of the American Association of Physicists in Medicine, Minneapolis, Minnesota, July 22, 2007
  21. Khan FM, Doppke KP, Hogstrom KR, et al. Clinical electron-beam dosimetry: Report of AAPM radiation therapy committee task group no. 25. Med. Phys. 1991;18:73–109
  22. Watanabe Y. Derivation of linear attenuation coefficients from CT numbers for low-energy photons. Phys. Med. Biol. 1999;44:2201–2211
  23. White DR, Martin RJ, Darlison R. Epoxy resin based tissue substitutes. Br. J. Radiol. 1977;50:814–821
  24. Low D, Hogstrom K. Determination of the relative linear collision stopping power and linear scattering power of electron bolus material. Phys. Med. Biol. 1994;39:1063–1068
  25. Zajic V. LET: Energy versus LET versus Range calculator v. 1.24. New York: Brookhaven National Laboratory.
  26. Berger MJ, Hubbell JH. XCOM: Photon cross-sections on a personal computer. American Association of Physicists in Medicine; 1988;
  27. Siebers JV, Miller DW, Moyers MF. Routine quality assurance for a proton radiation therapy facility. Particles. 1992;10:A7
  28. Moyers MF, Ghebremedhin A, Shahnazi K, et al. Calibration of a proton beam energy monitor. Med. Phys. 2004;31:1867
  29. Moyers MF, Ghebremedhin A, Arjomandy B, et al. Spill-to-spill and daily energy consistency with a new accelerator control system. PTCOG 41 Program Abstracts; 12, 2004;
  30. Moyers MF, Coutrakon GB, Ghebremedhin A, et al. Calibration of a proton beam energy monitor. Med. Phys. 2007;34:1952–1966
  31. Moyers MF, Ghebremedhin A. Spill-to-spill and daily proton energy consistency with a new accelerator control system. Med. Phys. 2008;35:1901–1905
  32. Coutrakon GB, Cortese J, Ghebremedhin A, et al. Microdosimetry spectra of the Loma Linda proton beam and relative biological effectiveness comparisons. Med. Phys. 1997;24:1499–1506
  33. Cann CE. Quantitative CT applications: Comparison of current scanners. Radiology. 1987;162:257–261
  34. Chen GTY, Singh RP, Castro JR, et al. Treatment planning for heavy ion radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 1979;5:1809–1819
  35. Constantinou C, Harrington JC, DeWerd LA. An electron density calibration phantom for CT-based treatment planning computers. Med. Phys. 1992;19:325–327
  36. American College of Radiology. Computed tomography (CT) accreditation program phantom testing criteria. Reston, VA: American College of Radiology; 2003;
  37. CT HiLight Advantage User Guide, Direction 18200, Rev. 6, Operator Reference 2-498. General Electric.
  38. Woodard HQ, White DR. The composition of body tissues. Br. J. Radiol. 1986;59:1209–1219
  39. Scott JE. The chemical morphology of the vitreous. Eye. 1992;6:553–555
  40. Jaffe NS. The vitreous in clinical ophthalmology. Saint Louis: The C. V. Mosby Co; 1969;
  41. Pirie A, van Heyningen R. Biochemistry of the eye. Oxford: Blackwell Scientific Publications; 1956;
  42. Parker RP, Hobday PA, Cassell KJ. The direct use of CT numbers in radiotherapy dosage calculations for inhomogeneous media. Phys. Med. Biol. 1979;24:802–809
  43. Kijewski PK, Bjarngard BE. The use of computed tomography data for radiotherapy dose calculations. Int. J. Radiat. Oncol. Biol. Phys. 1978;4:429–435
  44. International Commission on Radiological Units and Measurements. Stopping Powers and Ranges for protons and alpha particles. Report 49 Bethesda, MD: ICRU; 1993;
  45. Seltzer SM, Inokuti M, Paul H, et al. Response to the commentary by J. F. Ziegler regarding ICRU Report 49: stopping powers and ranges for protons and alpha particles (ICRU News). http://www.icru.org
  46. Bischel H, Hiraoka T. Energy loss of 70 MeV protons in elements. Nucl. Instrum. Methods. Phys. Res. 1992;B66:345–351
  47. Bischel H, Hiraoka T, Omata K. Aspects of fast-ion dosimetry. Radiat. Res. 2000;153:208–219
  48. Dingfelder M, Hantke D, Inokuti M, et al. Electron inelastic-scattering cross sections in liquid water. Radiat. Phys. Chem. 1999;53:1–18
  49. Kramer M, Jakel O, Haberer T, et al. Treatment planning for heavy-ion radiotherapy: Physical beam model and dose optimization. Phys. Med. Biol. 2000;45:3299–3317

PII: S0958-3947(09)00051-X

doi: 10.1016/j.meddos.2009.05.004

Medical Dosimetry
Volume 35, Issue 3 , Pages 179-194 , Autumn 2010